Skip to main content

CARBOPLATIN

NDC 69339-364 · Natco Pharma USA LLC

Generic nameCARBOPLATIN
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)CARBOPLATIN
Strength50 mg/5mL
Pharmacologic classPlatinum-based Drug [EPC], Platinum-containing Compounds [EXT]
Marketing categoryANDA

Packages

69339-364-05 — 1 VIAL, MULTI-DOSE in 1 CARTON (69339-364-05) / 5 mL in 1 VIAL, MULTI-DOSE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60505-6282 — CARBOPLATIN, 61703-150 — Carboplatin, 61703-262 — Carboplatin, 61703-339 — Carboplatin, 61703-360 — Carboplatin, 61703-600 — Carboplatin, 63323-172 — CARBOPLATIN, 68083-190 — Carboplatin, 68083-191 — Carboplatin, 68083-192 — Carboplatin, 68083-193 — Carboplatin, 69339-365 — CARBOPLATIN, 69339-366 — CARBOPLATIN, 69339-367 — CARBOPLATIN, 82511-003 — CARBOPLATIN, 82511-004 — CARBOPLATIN, 82511-005 — CARBOPLATIN, 82511-006 — CARBOPLATIN, 83831-141 — CARBOplatin, 83831-142 — CARBOplatin, +13 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels